Patent · US Active

Diagnosis of cancer

US12306174B2 · kind B2 · utility

0Cited by
1References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 4, 2019
Grant dateMay 20, 2025
Priority date
Expiry dateFeb 11, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7028
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

A method for the early detection and monitoring of the progression of cancer by detecting breath biomarkers is provided. The method comprises assessing the activity of an aldo-keto reductase by measuring the concentration of an exogenous substrate for said enzyme and/or measuring the concentration of a metabolite of said substrate in exhaled breath of a subject. Preferably, the cancer is lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.